LTA4H | Leukotriene A4 hydrolase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MEP1B | Meprin A, beta | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
METAP1 | Methionyl aminopeptidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
METAP1D | Methionyl aminopeptidase type 1D (mitochondrial) | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
METAP2 | Methionyl aminopeptidase 2 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MIPEP | Mitochondrial intermediate peptidase | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MMEL1 | Membrane metallo-endopeptidase-like 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
MMP1 | Matrix metallopeptidase 1 (interstitial collagenase) | Cancer-related genes Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MMP10 | Matrix metallopeptidase 10 (stromelysin 2) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MMP11 | Matrix metallopeptidase 11 (stromelysin 3) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
MMP12 | Matrix metallopeptidase 12 (macrophage elastase) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
MMP13 | Matrix metallopeptidase 13 (collagenase 3) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
MMP14 | Matrix metallopeptidase 14 (membrane-inserted) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MMP15 | Matrix metallopeptidase 15 (membrane-inserted) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
MMP16 | Matrix metallopeptidase 16 (membrane-inserted) | Cancer-related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MMP17 | Matrix metallopeptidase 17 (membrane-inserted) | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MMP19 | Matrix metallopeptidase 19 | Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
MMP2 | Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
MMP20 | Matrix metallopeptidase 20 | Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Not detected |
MMP21 | Matrix metallopeptidase 21 | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
MMP23B | Matrix metallopeptidase 23B | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Mixed |
MMP24 | Matrix metallopeptidase 24 (membrane-inserted) | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
MMP25 | Matrix metallopeptidase 25 | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MMP26 | Matrix metallopeptidase 26 | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MMP27 | Matrix metallopeptidase 27 | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
MMP28 | Matrix metallopeptidase 28 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
MMP3 | Matrix metallopeptidase 3 (stromelysin 1, progelatinase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
MMP7 | Matrix metallopeptidase 7 (matrilysin, uterine) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MMP8 | Matrix metallopeptidase 8 (neutrophil collagenase) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MPND | MPN domain containing | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
MYSM1 | Myb-like, SWIRM and MPN domains 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
NAALAD2 | N-acetylated alpha-linked acidic dipeptidase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NAALADL1 | N-acetylated alpha-linked acidic dipeptidase-like 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
NAALADL2 | N-acetylated alpha-linked acidic dipeptidase-like 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
NLN | Neurolysin (metallopeptidase M3 family) | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
NPEPL1 | Aminopeptidase-like 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
NPEPPS | Aminopeptidase puromycin sensitive | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
NRD1 | Nardilysin (N-arginine dibasic convertase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
OMA1 | OMA1 zinc metallopeptidase | Cancer-related genes Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PA2G4 | Proliferation-associated 2G4, 38kDa | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PAPPA | Pregnancy-associated plasma protein A, pappalysin 1 | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PAPPA2 | Pappalysin 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PEPD | Peptidase D | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PHEX | Phosphate regulating endopeptidase homolog, X-linked | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
PITRM1 | Pitrilysin metallopeptidase 1 | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PM20D1 | Peptidase M20 domain containing 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |